MYLOTARG dosage regimens vary based on the indication (newly-diagnosed vs. relapsed/refractory AML), patient population (adults vs. pediatrics), and whether it's used in combination or as a single agent, with specific adjustments for body surface area in children. 

MYLOTARG Dosing Regimens and Administration Guidelines 

Will detail specific mg/m² or mg/kg doses, administration schedules (Days 1, 4, 7; or Day 1 and Day 8, etc.), and differences between induction, consolidation, and continuation phases. Mention the single-dose vial size (4.5 mg) and limitations (e.g., "up to one 4.5 mg vial" for certain regimens). Include premedication requirements.